Fintel reports that on January 10, 2025, JMP Securities downgraded their outlook for Paycor HCM (NasdaqGS:PYCR) from Market ...

JMP Securities analyst Constantine Davides lowered the firm’s price target on Evolent Health (EVH) to $18 from $27 and keeps an Outperform ...

JMP Securities analyst Mitchell Germain maintained a Hold rating on W. P. Carey Inc. (WPC – Research Report) today. The company’s shares closed ...

JMP Securities reissued their market perform rating on shares of Stryker (NYSE:SYK – Free Report) in a research note issued ...

Fintel reports that on January 8, 2025, JMP Securities initiated coverage of Context Therapeutics (NasdaqCM:CNTX) with a ...

Context Therapeutics (NASDAQ:CNTX – Get Free Report) was upgraded by Citizens Jmp to a “strong-buy” rating in a note issued ...

JMP Securities has recently reduced Uber Technologies Inc (UBER) stock to Mkt Perform rating, as announced on January 2, 2025, according to Finviz. Earlier, on October 31, 2024, Gordon Haskett had ...

JMP Securities has downgraded Alphabet shares (GOOG, GOOGL) to Market Perform from Outperform, citing concerns over pending antitrust litigation.The firm believes the Department of Justice case ...

JMP Securities analyst Aaron Kimson downgraded Expensify (EXFY) to Market Perform from Outperform without a price target The firm says its thesis has played out. The stock has increased 38% year ...

JMP Securities analyst Silvan Tuerkcan initiated coverage of Solid Biosciences (SLDB) with an Outperform rating and $15 price target Solid is a clinical-stage biotechnology company focused on ...